NCT02535416View on ClinicalTrials.gov

A Study of ARC-520 at Varying Infusion Rates in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Healthy
Interventions
DRUG

ARC-520

DRUG

cetirizine

DRUG

diphenhydramine

Trial Locations (1)

4029

QPharm, Pty Limited, Royal Brisbane Hospital, Herston

Sponsors
All Listed Sponsors
lead

Arrowhead Pharmaceuticals

INDUSTRY